Advanced search
Publication Cover
Current Medical Research and Opinion Volume 36, 2020 - Issue 5
Submit an article Journal homepage
402
Views
14
CrossRef citations to date
0
Altmetric
Diabetes

Use of oral antidiabetic drugs in Japanese working-age patients with type 2 diabetes mellitus: dosing pattern for metformin initiators

Toshiki KamedaDepartment of Health Policy and Management, Keio University School of Medicine, Tokyo, Japan;
,
Hiraku KumamaruDepartment of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-9759-6191
ORCID Icon,
Shiori NishimuraDepartment of Health Policy and Management, Keio University School of Medicine, Tokyo, Japan; ;Department of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan;
,
Shun KohsakaDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan
&
Hiroaki MiyataDepartment of Health Policy and Management, Keio University School of Medicine, Tokyo, Japan; ;Department of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan;
Pages 749-756 | Received 12 Oct 2019, Accepted 01 Feb 2020, Published online: 27 Feb 2020

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Keizo Kanasaki, Shen Qu, Fumiko Yamamoto, Cornelia Schepers, Rafael Sani Simões, Daisuke Yabe & Linong Ji. (2022) Safety and tolerability of linagliptin in Asians with type 2 diabetes: a pooled analysis of 4457 patients from 21 randomized, double-blind, placebo-controlled clinical trials. Expert Opinion on Drug Safety 21:3, pages 425-434.
Read now

Articles from other publishers (13)

Sanghwa Park, Jiseon Jeong, Yunna Woo, Yeo Jin Choi & Sooyoung Shin. (2023) Incident infection risks depending on oral antidiabetic exposure in insulin-treated type 2 diabetes patients. Scientific Reports 13:1.
Crossref
Shinichiro Shirabe, Katsuya Yamazaki, Mariko Oishi, Keiko Arai, Noriharu Yagi, Manaka Sato, Masakazu Takeuchi, Takahito Kai & Hiroshi Maegawa. (2022) Changes in prescription patterns and doses of oral antidiabetic drugs in Japanese patients with type 2 diabetes (JDDM70). Journal of Diabetes Investigation 14:1, pages 75-80.
Crossref
Atsushi Tajima, Keisuke Tobe, Jun-ichi Eiki, Hideki Origasa, Hirotaka Watada, Iichiro Shimomura, Shigeru Tokita & Takashi Kadowaki. (2022) Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND). BMJ Open Diabetes Research & Care 10:6, pages e003032.
Crossref
Hiroshi Nomoto, Akihiro Takahashi, Akinobu Nakamura, Hiroyoshi Kurihara, Jun Takeuchi, So Nagai, Shinji Taneda, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Hideaki Miyoshi & Tatsuya Atsumi. (2022) Add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: study protocol for a multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study). BMJ Open Diabetes Research & Care 10:6, pages e002988.
Crossref
Zi‐Yang Peng, Chun‐Ting Yang, Huang‐Tz Ou & Shihchen Kuo. (2022) Cost‐effectiveness of sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors among patients with type 2 diabetes with and without established cardiovascular diseases: A model‐based simulation analysis using 10‐year real‐world data and targeted literature review. Diabetes, Obesity and Metabolism 24:7, pages 1328-1337.
Crossref
Toshiya Machida, Taku Obara, Makoto Miyazaki, Jun Inoue & Nariyasu Mano. (2022) Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver disease. Annals of Hepatology 27:4, pages 100699.
Crossref
Rimei Nishimura, Mayumi Taniguchi, Tomomi Takeshima & Kosuke Iwasaki. (2021) Efficacy and Safety of Metformin Versus the Other Oral Antidiabetic Drugs in Japanese Type 2 Diabetes Patients: A Network Meta-analysis. Advances in Therapy 39:1, pages 632-654.
Crossref
Yoshinori Takeuchi, Hiraku Kumamaru, Yasuhiro Hagiwara, Hiroki Matsui, Hideo Yasunaga, Hiroaki Miyata & Yutaka Matsuyama. (2021) Sodium‐glucose cotransporter‐2 inhibitors and the risk of urinary tract infection among diabetic patients in Japan: Target trial emulation using a nationwide administrative claims database. Diabetes, Obesity and Metabolism 23:6, pages 1379-1388.
Crossref
Yoshio Nagai, Kiyoyasu Kazumori, Tomomi Takeshima, Kosuke Iwasaki & Yasushi Tanaka. (2021) A Claims Database Analysis of Dose-Dependency of Metformin and Incidence of Lactic Acidosis in Japanese Patients with Type 2 Diabetes. Diabetes Therapy 12:4, pages 1129-1141.
Crossref
Yoshio Nagai, Kiyoyasu Kazumori, Tomomi Takeshima, Kosuke Iwasaki & Yasushi Tanaka. (2021) Effects of Increasing Metformin Dose vs Adding/Switching to Dipeptidyl Peptidase-4 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes. Diabetes Therapy 12:3, pages 897-911.
Crossref
Yoshitaka Hashimoto, Hisami YasuzawaTsutomu IshidaYuichi MiyazakiMichiaki Fukui. (2021) A survey on consciousness towards the proper use of metformin and medical cost in Japanese patients with type 2 diabetes. Journal of Clinical Biochemistry and Nutrition 69:3, pages 286-293.
Crossref
Masaya Koshizaka, Ko Ishikawa, Ryoichi Ishibashi, Sho Takahashi, Kenichi Sakamoto, Hidetaka Yokoh, Yusuke Baba, Shintaro Ide, Kana Ide, Takahiro Ishikawa, Shunichiro Onishi, Kazuki Kobayashi, Minoru Takemoto, Takuro Horikoshi, Ryota Shimofusa, Yoshiro Maezawa & Koutaro Yokote. (2020) Comparison of Visceral Fat Reduction by Ipragliflozin and Metformin in Elderly Type 2 Diabetes Patients: Sub-Analysis of a Randomized-Controlled Study. Diabetes Therapy 12:1, pages 183-196.
Crossref
Haixia Chen & Yangpeng Lu. 2021. Structure and Health Effects of Natural Products on Diabetes Mellitus. Structure and Health Effects of Natural Products on Diabetes Mellitus 17 32 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.